Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing
Open Access
- 14 December 2008
- journal article
- research article
- Published by Springer Nature in Nature Methods
- Vol. 6 (1), 67-69
- https://doi.org/10.1038/nmeth.1286
Abstract
This variant ascertainment algorithm, or VAAL, uses short sequence reads of haploid bacterial genomes to first locally assemble the reads and then compare these assemblies to the reference genome. This allows VAAL to detect all types of variants ranging from single-nucleotide polymorphisms to large insertions or deletions. Our variant ascertainment algorithm, VAAL, uses massively parallel DNA sequence data to identify differences between bacterial genomes with high sensitivity and specificity. VAAL detected ∼98% of differences (including large insertion-deletions) between pairs of strains from three species while calling no false positives. VAAL also pinpointed a single mutation between Vibrio cholerae genomes, identifying an antibiotic's site of action by identifying sequence differences between drug-sensitive strains and drug-resistant derivatives.This publication has 18 references indexed in Scilit:
- Accurate whole human genome sequencing using reversible terminator chemistryNature, 2008
- Mapping short DNA sequencing reads and calling variants using mapping quality scoresGenome Research, 2008
- High-throughput sequencing provides insights into genome variation and evolution in Salmonella TyphiNature Genetics, 2008
- Single-Molecule DNA Sequencing of a Viral GenomeScience, 2008
- Velvet: Algorithms for de novo short read assembly using de Bruijn graphsGenome Research, 2008
- ALLPATHS: De novo assembly of whole-genome shotgun microreadsGenome Research, 2008
- Quality scores and SNP detection in sequencing-by-synthesis systemsGenome Research, 2008
- Comprehensive mutation identification in an evolved bacterial cooperator and its cheating ancestorProceedings of the National Academy of Sciences, 2006
- The Race for the $1000 GenomeScience, 2006
- TB--A New Target, a New DrugScience, 2005